| # | Drug | Count |
|---|---|---|
| 0 | ETOPOSIDE | 28 |
| 1 | CELECOXIB | 19 |
| 2 | FENOFIBRATE | 19 |
| 3 | CIPROFLOXACIN | 16 |
| 4 | CIPROFLOXACIN HYDROCHLORIDE | 16 |
| 5 | CIPROFLOXACIN TABLETS | 15 |
| 6 | CIPROFOLXACIN | 15 |
| 7 | TEMOZOLOMIDE | 13 |
| 8 | CYCLOPHOSPHAMIDE | 11 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RILZABRUTINIB | 1 | 0.0018 |
| 1 | SARGRAMOSTIM | 2 | 0.0012 |
| 2 | NELFINAVIR MESYLATE | 2 | 0.0010 |
| 3 | ROPIVACAINE HYDROCHLORIDE | 2 | 0.0008 |
| 4 | ERDAFITINIB | 1 | 0.0008 |
| 5 | PSYLLIUM HUSK | 1 | 0.0007 |
| 6 | CLEMASTINE FUMARATE | 1 | 0.0007 |
| 7 | NEVIRAPINE | 6 | 0.0007 |
| 8 | TEMOZOLOMIDE | 13 | 0.0006 |
| 9 | FENOFIBRATE | 19 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 28 | 0.0004 |
| 1 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 19 | 0.0003 |
| 2 | Human C1 Esterase Inhibitor [EPC] | 1 | 0.0003 |
| 3 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0002 |
| 4 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 5 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 6 | Fluoroquinolone Antibacterial [EPC] | 15 | 0.0001 |
| 7 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 8 | Alkylating Drug [EPC] | 24 | 0.0001 |
| 9 | Antisense Oligonucleotide [EPC] | 1 | 0.0001 |